NRBO

NeuroBo Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Strategic Update

NRBO Stock Price Increases Over 5% Pre-Market: Why It Happened

NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene

NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement

NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program

NeuroBo Pharmaceuticals (NRBO) Surges: Stock Moves 5.2% Higher